Site dependent intestinal absorption of darunavir and its interaction with ketoconazole

European Journal of Pharmaceutical Sciences

Volumn 49, Issue 1, 2013, Pages 51-56

  Stappaerts, Jef ^a   Annaert, Pieter ^a   Augustijns, Patrick ^a  

^a DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

Author keywords

Darunavir; In situ perfusion; Ketoconazole; P gp; P450; Site dependent absorption

Indexed keywords

CYTOCHROME P450; DARUNAVIR; KETOCONAZOLE; MULTIDRUG RESISTANCE PROTEIN; ZOSUQUIDAR; SULFONAMIDE;

ANIMAL EXPERIMENT; ARTICLE; DRUG ABSORPTION; DRUG TRANSPORT; DUODENUM; HUMAN; HUMAN CELL; ILEUM; INTESTINE ABSORPTION; INTESTINE PERFUSION; JEJUNUM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; CACO 2 CELL LINE; CHEMISTRY; INTESTINE; METABOLISM; PERMEABILITY; SPRAGUE DAWLEY RAT; TUMOR CELL CULTURE;

ANIMALS; CACO-2 CELLS; HUMANS; INTESTINAL ABSORPTION; INTESTINES; KETOCONAZOLE; MALE; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES; TUMOR CELLS, CULTURED;

EID: 84874941767     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.01.015     Document Type: Article

References (31)

1. M. Achira, H. Suzuki, K. Ito, and Y. Sugiyama Comparative studies to determine the selective inhibitors for P-glycoprotein and cytochrome P4503A4 AAPS Pharm. Sci. 1 1999 E18
2. H. Arakawa, Y. Shirasaka, M. Haga, T. Nakanishi, and I. Tamai Active intestinal absorption of fluoroquinolone antibacterial agent ciprofloxacin by organic anion transporting polypeptide, Oatp1a5 Biopharm. Drug. Dispos. 33 2012 332 341
3. P. Artursson, K. Palm, and K. Luthman Caco-2 monolayers in experimental and theoretical predictions of drug transport Adv. Drug. Deliv. Rev. 46 2001 27 43
4. R.S. Autar, F.W.N.M. Wit, J. Sankote, D. Sutthichom, E. Kimenai, E. Hassink, A. Hill, D.A. Cooper, P. Phanuphak, J.M.A. Lange, D.M. Burger, and K. Ruxrungtham Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in Thai HIV-1 infected patients AIDS 21 2007 1535 1539 (Pubitemid 47075473)
5. S.K. Balani, T. Zhu, T.J. Yang, Z. Liu, B. He, and F.W. Lee Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in rats, dogs, and monkeys Drug. Metab. Dispos. 30 2002 1059 1062
6. S. Berggren, C. Gall, N. Wollnitz, M. Ekelund, U. Karlbom, J. Hoogstraate, D. Schrenk, and H. Lennernäs Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine Mol. Pharm. 4 2007 252 257 (Pubitemid 46640601)
7. J. Brouwers, J. Tack, and P. Augustijns In vitro behavior of a phosphate ester prodrug of amprenavir in human intestinal fluids and in the Caco-2 system: illustration of intraluminal supersaturation Int. J. Pharm. 336 2007 302 309 (Pubitemid 46670658)
8. S.T. Buckley, S.M. Fischer, G. Fricker, and M. Brandl In vitro models to evaluate the permeability of poorly soluble drug entities: challenges and perspectives Eur. J. Pharm. Sci. 45 2012 235 250
9. R. Canaparo, N. Finnström, L. Serpe, A. Nordmark, E. Muntoni, M. Eandi, A. Rane, and G.P. Zara Expression of CYP3A isoforms and P-glycoprotein in human stomach, jejunum and ileum Clin. Exp. Pharmacol. Physiol. 34 2007 1138 1144 (Pubitemid 47416351)
10. X. Cao, L.X. Yu, C. Barbaciru, C.P. Landowski, H.-C. Shin, S. Gibbs, H.A. Miller, G.L. Amidon, and D. Sun Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability Mol. Pharm. 2 2005 329 340 (Pubitemid 41186409)
11. S. Deferme, J. Tack, F. Lammert, and P. Augustijns P-glycoprotein attenuating effect of human intestinal fluid Pharm. Res. 20 2003 900 903 (Pubitemid 36628437)
12. M.E. Elsherbiny, A.O.S. El-Kadi, and D.R. Brocks The metabolism of amiodarone by various CYP isoenzymes of human and rat, and the inhibitory influence of ketoconazole J. Pharm. Pharm. Sci. 11 2008 147 159
13. G. Englund, F. Rorsman, A. Rönnblom, U. Karlbom, L. Lazorova, J. Gråsjö, A. Kindmark, and P. Artursson Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells Eur. J. Pharm. Sci. 29 2006 269 277 (Pubitemid 44602404)
14. B. Hagenbuch, and C. Gui Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family Xenobiotica 38 2008 778 801
15. I.S. Haslam, J.A. Wright, D.A. O'Reilly, D.J. Sherlock, T. Coleman, and N.L. Simmons Intestinal ciprofloxacin efflux: the role of breast cancer resistance protein (ABCG2) Drug. Metab. Dispos. 39 2011 2321 2328
16. Holmstock, N., Annaert, P., Augustijns, P., 2012. Boosting of HIV protease inhibitors by ritonavir in the intestine: the relative role of cytochrome P450 and P-glycoprotein inhibition based on Caco-2 monolayers versus in situ intestinal perfusion in mice. Drug. Metab. Dispos. 40, 1473-1477.
17. N. Holmstock, R. Mols, P. Annaert, and P. Augustijns In situ intestinal perfusion in knockout mice demonstrates inhibition of intestinal p-glycoprotein by ritonavir causing increased darunavir absorption Drug. Metab. Dispos. 38 2010 1407 1410
18. F. Ingels, B. Beck, M. Oth, and P. Augustijns Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers Int. J. pharm. 274 2004 221 232 (Pubitemid 38457021)
19. M. Jin, T. Shimada, K. Yokogawa, M. Nomura, J. Ishizaki, Y. Piao, Y. Kato, A. Tsuji, and K.-I. Miyamoto Site-dependent contributions of P-glycoprotein and CYP3A to cyclosporin a absorption, and effect of dexamethasone in small intestine of mice Biochem. Pharmacol. 72 2006 1042 1050 (Pubitemid 44374466)
20. L.Y. Li, G.L. Amidon, J.S. Kim, T. Heimbach, F. Kesisoglou, J.T. Topliss, and D. Fleisher Intestinal metabolism promotes regional differences in apical uptake of indinavir: coupled effect of P-glycoprotein and cytochrome P450 3A on indinavir membrane permeability in rat J. Pharmacol. Exp. Ther. 301 2002 586 593 (Pubitemid 34429971)
21. M. Li, L. Si, H. Pan, A.K. Rabba, F. Yan, J. Qiu, and G. Li Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion Int. J. Pharm. 403 2011 37 45
22. C. MacLean, U. Moenning, A. Reichel, and G. Fricker Closing the gaps: a full scan of the intestinal expression of p-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein two in male and female rats Drug. Metab. Dispos. 36 2008 1249 1254 (Pubitemid 351929307)
23. C. MacLean, U. Moenning, A. Reichel, and G. Fricker Regional absorption of fexofenadine in rat intestine Eur. J. Pharm. Sci. 41 2010 670 674
24. D. Mitschke, A. Reichel, G. Fricker, and U. Moenning Characterization of cytochrome P450 protein expression along the entire length of the intestine of male and female rats Drug. Metab. Dispos. 36 2008 1039 1045 (Pubitemid 351717460)
25. S. Mouly, and M.F. Paine P-glycoprotein increases from proximal to distal regions of human small intestine Pharm. Res. 20 2003 1595 1599 (Pubitemid 37268274)
26. D.R. Mudra, K.E. Desino, and P.V. Desai In silico, in vitro and in situ models to assess interplay between CYP3A and P-gp Curr. Drug. Metab. 12 2011 750 773
27. M.A. Quevedo, L.E. Nieto, and M.C. Briñón P-glycoprotein limits the absorption of the antiHIV drug zidovudine through rat intestinal segments Eur. J. Pharm. Sci. 43 2011 151 159
28. M. Rittweger, and K. Arastéh Clinical pharmacokinetics of darunavir Clin. Pharmacokinet. 46 2007 739 756 (Pubitemid 47347446)
29. V.J. Sekar, E. Lefebvre, M. De Pauw, T. Vangeneugden, and R.M. Hoetelmans Pharmacokinetics of darunavir/ritonavir and ketoconazole following co-administration in HIV-healthy volunteers Br. J. Clin. Pharmacol. 66 2008 215 221
30. T.J. Strelevitz, R.S. Foti, and M.B. Fisher In vivo use of the P450 inactivator 1-aminobenzotriazole in the rat: varied dosing route to elucidate gut and liver contributions to first-pass and systemic clearance J. Pharm. Sci. 95 2006 1334 1341 (Pubitemid 43874447)
31. K. Takara, N. Ohnishi, S. Horibe, and T. Yokoyama Expression profiles of drug-metabolizing enzyme CYP3A and drug efflux transporter multidrug resistance 1 subfamily mRNAS in small intestine Drug. Metab. Dispos. 31 2003 1235 1239 (Pubitemid 37152974)